Search for: "Smith v. Mylan Inc." Results 21 - 40 of 48
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2016, 11:39 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
1 Jan 2016, 9:00 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
1 Sep 2014, 7:04 am
Entries should be emailed to katcontest1@gmail.com by Monday 8 September 11 pm GMT. * Letter from AmeriKat: Judge Koh declares Takeda takes it too far with Mylan Dexilant declaration: The AmeriKat is back with a case review of Takeda Pharmaceutical Co., Ltd. et al v Mylan Inc. et al (here). [read post]
18 Jul 2014, 11:55 am
Smith & Nephew, 2005 WL 3470337, at *5 (M.D. [read post]
28 Mar 2014, 5:33 pm
Category: Infringement       By: Eric Paul Smith, Contributor   TitlePfizer Inc. v. [read post]
9 Aug 2012, 5:00 am by Bexis
With Bexis and McConnell now at Reed Smith, we’ve gained access to Reed’s database on the ubiquitous plaintiffs’ expert Dr. [read post]
18 Jul 2012, 4:52 am
" It follows that, as Pumfrey J said in Halliburton Energy Services Inc v Smith International (North Sea) Ltd [2005] EWHC 1623 (Pat), [2006] RPC at [60] "over-meticulousness is not to be equated to carefulness. [read post]
16 May 2012, 12:22 pm by Bexis
Mylan Pharmaceuticals, Inc., ___ F. [read post]
7 May 2012, 5:00 am by Bexis
Smith & Nephew, Inc., 482 F.3d 1187, 1194 (9th Cir. 2007); Phelps v. [read post]
7 Sep 2011, 4:22 am by Marie Louise
(Kluwer Patent Blog) Fortical (Calcitonin-salmon) – US: Obviousness in chemical formulations: (unclaimed) purpose of limitation leads to nonobviousness holding: Unigene Labs. and Upsher-Smith Labs v. [read post]